In obesity, increased visfatin levels are related to a regulatory response to maintain glucose in stable levels; however, if the threshold is exceeded, visfatin is associated with inflammation and T2D, IR, CVD, and renal damage [51,52]. This evidence concerns the gene NAMPT and type 2 diabetes mellitus.